Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery

Raahilah, Zahir Essa and Wu, Yuan Seng * and Kalaivani, Batumalaie and Mahendran, Sekar and Poh, Chit Laa * (2022) Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery. Pharmacological Reports, 74. pp. 1166-1181. ISSN 2299-5684

[img]
Preview
Text
Wu Yuan Seng_Antiviral peptides against SARS-CoV-2.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
Official URL: https://link.springer.com/article/10.1007/s43440-0...

Abstract

The global pandemic of COVID-19 is a serious public health concern. Over 625 million confirmed cases and more than 6 million deaths have been recorded worldwide. Although several vaccines and antiviral medications have been developed, their efficacy is limited by the emerging new SARS-CoV-2 strains. Peptide-based therapeutics is a fast-growing class of new drugs and have unique advantages over large proteins and small molecules. Antiviral peptides (AVPs) are short polycationic antivirals with broad-spectrum effects, which have been shown to exert both prophylactic and therapeutic actions against reported coronaviruses. The potential therapeutic targets of AVPs are located either on the virus (e.g., E-protein and S-protein) to prohibit viral binding or host cells, particularly, those present on the cell surface (e.g., ACE2 and TMPRSS2). Despite AVPs having promising antiviral effects, their efficacy is limited by low bioavailability. Thus, nanoformulation is a prerequisite for prolonged bioavailability and efficient delivery. This review aimed to present an insight into the therapeutic AVP targets on both virus and host cells by discussing their antiviral activities and associated molecular mechanisms. Besides, it described the technique for discovering and developing possible AVPs based on their targets, as well as the significance of using nanotechnology for their efficient delivery against SARS-CoV-2.

Item Type: Article
Uncontrolled Keywords: Antiviral peptides; COVID-19; Efficient delivery; Nanoformulation; Peptidase therapeutics; SARS-CoV-2; Therapeutic targets.
Subjects: R Medicine > RA Public aspects of medicine
R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Others > Non Sunway Academics
Sunway University > School of Medical and Life Sciences [formerly School of Healthcare and Medical Sciences until 2020] > Sunway Microbiome Centre [formerly Centre for Virus and Vaccine Research until 2023]
Depositing User: Ms Yong Yee Chan
Related URLs:
Date Deposited: 10 Aug 2024 08:58
Last Modified: 10 Aug 2024 08:58
URI: http://eprints.sunway.edu.my/id/eprint/3053

Actions (login required)

View Item View Item